Welcome to our latest blog post! Today, we're exploring the fascinating world of central retinal artery occlusion (CRAO) – a condition that affects millions of people around the globe. As medical professionals, it's essential to understand this eye condition thoroughly so you can diagnose and treat it effectively. In this article, we'll discuss the different types of CRAO, how it's diagnosed, its causes, symptoms and treatment options available. So sit back and get ready for an informative read on everything you need to know about central retinal artery occlusion!
There are two types of central retinal artery occlusion (CRAO) – non-arteritic and arteritic. Non-arteritic CRAO is the most common type, accounting for around 90% of cases. It occurs when a blood clot or other blockage forms in the central retinal artery, which supplies oxygen and nutrients to the retina.
Arteritic CRAO, on the other hand, is much less common but more severe. It's caused by inflammation and narrowing of the arteries due to an autoimmune disease called giant cell arteritis (GCA). This condition affects people over 50 years old and requires immediate treatment with high-dose corticosteroids to prevent permanent vision loss.
Central Retinal Artery Occlusion (CRAO) is a medical emergency that requires urgent diagnosis and treatment. The diagnosis process usually begins with a thorough eye examination, including an assessment of visual acuity, intraocular pressure, pupil reactions, and the appearance of the retina.
Ophthalmoscopy is another diagnostic tool that can help identify CRAO. During this procedure, an ophthalmologist or optometrist will examine the inside of your eye using a specialized instrument called an ophthalmoscope.
In addition to these methods, imaging tests such as fluorescein angiography and optical coherence tomography (OCT) may also be used to diagnose CRAO. These tests can provide detailed images of the blood vessels in your eyes and detect any blockages or abnormalities.
One of the most common treatments for CRAO is ocular massage, which involves applying gentle pressure on the closed eyelids to help dislodge any blockages in the central retinal artery. Another treatment option is administering drugs that dilate blood vessels and increase blood flow to the retina.
Central retinal artery occlusion is a serious eye condition that can lead to permanent vision loss if not diagnosed and treated promptly. Medical professionals should be aware of the different types, causes, symptoms and diagnostic methods for CRAO in order to provide effective treatment and prevent further complications.
Early diagnosis with fundus examination or OCT angiography followed by immediate management including ocular massage, anterior chamber paracentesis or hyperbaric oxygen therapy can help improve visual outcomes in patients with central retinal artery occlusion.
It's also important for medical professionals to educate their patients on the risk factors associated with this condition such as hypertension, diabetes mellitus and high cholesterol levels. Encouraging regular eye exams can help detect any changes early on before they progress into more serious conditions like CRAO.
Understanding the nuances of central retinal artery occlusion is key in providing optimal care for patients experiencing this condition.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation